FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
Go back to FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 7.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.08 | 52 Week High | $5.40 | |||
| Open | $7.08 | 52 Week Low | $1.88 | |||
| Day High | $7.08 | P/E | N/A | |||
| Day Low | $7.08 | EPS | $0.00 | |||
| Volume | 24,243 | |||||
| (AMEX: NPPNY) | Delayed: 5.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.61 | 52 Week High | $ | |||
| Open | $5.61 | 52 Week Low | $ | |||
| Day High | $5.61 | P/E | N/A | |||
| Day Low | $5.61 | EPS | $ | |||
| Volume | 1,044 | |||||
